Millennium Management LLC Reports 3.5% Stake in Larimar Therapeutics, Inc. (LRMR)

On April 30, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G/A regarding their holdings in Larimar Therapeutics, Inc. (LRMR). The filing indicates that as of March 31, 2026, the reporting persons collectively held 3,625,278 shares of common stock, representing a 3.5% ownership stake in the company. This reflects an increase from a previously reported 0.0% position, though the filing also notes that the reporting persons' ownership has fallen to 5% or less of the class of securities. The shares are held by entities subject to voting control and investment discretion by Millennium Management LLC, with Millennium Group Management LLC serving as the managing member and Israel A. Englander acting as the sole voting trustee of the managing member. The filing was made under Rule 13d-1(c), certifying that the shares were not acquired for the purpose of influencing or changing the control of the issuer.